Treating opiate dependence
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 19, 1990
Grant Date -
N/A
app pub date -
Nov 25, 1988
filing date -
Dec 3, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A pharmaceutical composition in sublingual unit dosage form for maintenance treatment of opiate addicts comprising from 2 to 8 mg buprenorphine and an amount of naltrexone sufficient to substantially attenuate the euphorigenic effect of the buprenorphine when injected and to provide greater opiate blocking effect than that of naltrexone alone.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully